Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial MEJ Lean, WS Leslie, AC Barnes, N Brosnahan, G Thom, L McCombie, ... The lancet Diabetes & endocrinology 7 (5), 344-355, 2019 | 888 | 2019 |
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial MEJ Lean, WS Leslie, AC Barnes, N Brosnahan, G Thom, L McCombie, ... The Lancet Diabetes & Endocrinology 7 (5), 344-355, 2019 | 882 | 2019 |
Thyroid hormone therapy for older adults with subclinical hypothyroidism DJ Stott, N Rodondi, PM Kearney, I Ford, RGJ Westendorp, SP Mooijaart, ... New England Journal of Medicine 376 (26), 2534-2544, 2017 | 534 | 2017 |
Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial JE Norman, N Marlow, CM Messow, A Shennan, PR Bennett, S Thornton, ... The Lancet 387 (10033), 2106-2116, 2016 | 497 | 2016 |
Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial JE Norman, N Marlow, CM Messow, A Shennan, PR Bennett, S Thornton, ... The lancet 387 (10033), 2106-2116, 2016 | 497 | 2016 |
Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised, controlled trial KW Muir, GA Ford, CM Messow, I Ford, A Murray, A Clifton, MM Brown, ... Journal of Neurology, Neurosurgery & Psychiatry, jnnp-2016-314117, 2016 | 354 | 2016 |
Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction C Espinola-Klein, HJ Rupprecht, C Bickel, K Lackner, S Savvidis, ... Circulation 118 (9), 961-967, 2008 | 263 | 2008 |
Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial MD Witham, RJG Price, AD Struthers, PT Donnan, CM Messow, I Ford, ... JAMA internal medicine 173 (18), 1672-1679, 2013 | 215 | 2013 |
Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial MD Witham, RJG Price, AD Struthers, PT Donnan, CM Messow, I Ford, ... JAMA internal medicine 173 (18), 1672-1679, 2013 | 215 | 2013 |
First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures M Savvidou, SM Nelson, M Makgoba, CM Messow, N Sattar, K Nicolaides Diabetes 59 (12), 3017-3022, 2010 | 213 | 2010 |
First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures M Savvidou, SM Nelson, M Makgoba, CM Messow, N Sattar, K Nicolaides Diabetes 59 (12), 3017-3022, 2010 | 213 | 2010 |
B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients F Post, LS Weilemann, CM Messow, C Sinning, T Münzel Critical care medicine 36 (11), 3030-3037, 2008 | 210 | 2008 |
First-trimester circulating 25-hydroxyvitamin D levels and development of gestational diabetes mellitus M Makgoba, SM Nelson, M Savvidou, CM Messow, K Nicolaides, N Sattar Diabetes care 34 (5), 1091-1093, 2011 | 207 | 2011 |
Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients SM Nelson, MC Messow, AM Wallace, R Fleming, A McConnachie Fertility and sterility 95 (2), 736-741. e3, 2011 | 198 | 2011 |
Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study T Keller, CM Messow, E Lubos, V Nicaud, PS Wild, HJ Rupprecht, ... European heart journal 30 (3), 314-320, 2009 | 195 | 2009 |
Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study R Schnabel, CM Messow, E Lubos, C Espinola-Klein, HJ Rupprecht, ... European heart journal 29 (5), 649-657, 2008 | 186 | 2008 |
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis MA Wörns, A Weinmann, K Pfingst, C Schulte-Sasse, CM Messow, ... Journal of clinical gastroenterology 43 (5), 489-495, 2009 | 180 | 2009 |
Resistin, acute coronary syndrome and prognosis results from the AtheroGene study E Lubos, CM Messow, R Schnabel, HJ Rupprecht, C Espinola-Klein, ... Atherosclerosis 193 (1), 121-128, 2007 | 172 | 2007 |
Resistin, Acute Coronary Syndrome and Prognosis: Results from the AtheroGene Study E Lubos, CM Messow, R Schnabel, HJ Rupprecht, C Espinola-Klein, ... Circulation 114 (Suppl 18), II_418-II_418, 2006 | 172 | 2006 |
Randomised, double-blind, placebo-controlled trials of non-individualised homeopathic treatment: systematic review and meta-analysis RT Mathie, N Ramparsad, LA Legg, J Clausen, S Moss, JRT Davidson, ... Systematic reviews 6 (1), 63, 2017 | 162 | 2017 |